EICHOR
● Completed
Pharmacology of Adjuvant Hormonotherapy in Breast Cancer
Condition: Hormono-depending Adjuvant Breast Cancer · Sponsor: Institut Claudius Regaud
About this study
This is a biomedical study of interventional type, multicenter, inter-regional. Patients with hormono-depending breast cancer, for which an indication of adjuvant hormonotherapy treatment (according to the current treatments) was retained, will be enrolled in this study. The main objective is to estimate the correlations between pharmacokinetic and pharmacogenetic parameters of adjuvant hormonal breast cancer treatment, during the first 3 years.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (24)
| Clinique Calabet | Agen, France | — |
| Clinique Claude Bernard | Albi, France | — |
| Centre Hospitalier d'Auch | Auch, France | — |
| CHU de Bordeaux | Bordeaux, France | — |
| Clinique Tivoli | Bordeaux, France | — |
| Institut Bergonié | Bordeaux, France | — |
| Polyclinique Bordeaux Nord | Bordeaux, France | — |
| Centre Hospitalier de Brive | Brive-la-Gaillarde, France | — |
| Centre Hospitalier de Cahors | Cahors, France | — |
| Centre Hospitalier Intercommunal de Castres-Mazamet | Castres, France | — |
| Hôpital Dupuytren CHU Limoges | Limoges, France | — |
| Centre Hospitalier de Mont de Marsan | Mont-de-Marsan, France | — |
+ 12 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01127295